
Becton, Dickinson and Company BDX
$ 147.79
-2.8%
Quarterly report 2026-Q2
added 05-07-2026
Becton, Dickinson and Company Cash and Cash Equivalents 2011-2026 | BDX
Annual Cash and Cash Equivalents Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 641 M | 1.72 B | 1.42 B | 1.01 B | 2.39 B | 2.92 B | 536 M | 1.14 B | 14.2 B | 1.54 B | 1.42 B | 1.86 B | 1.89 B | 1.67 B | 1.18 B | 1.22 B | 1.39 B | 830 M | 511 M | 1 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.2 B | 511 M | 2.02 B |
Quarterly Cash and Cash Equivalents Becton, Dickinson and Company
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 813 M | 740 M | 740 M | 735 M | 735 M | 667 M | 813 M | 4.46 B | 4.49 B | 2.39 B | 1.23 B | 923 M | 1.02 B | 2.07 B | 744 M | 1.01 B | 2.76 B | 3.32 B | 2.05 B | 2.28 B | 3.15 B | 2.28 B | 3.25 B | 2.82 B | 2.82 B | 2.82 B | 560 M | 536 M | 536 M | 536 M | 943 M | 1.14 B | 1.14 B | 1.14 B | 1.12 B | 14.2 B | 14.2 B | 14.2 B | 919 M | 1.54 B | 1.54 B | 919 M | 1.58 B | 1.42 B | 1.42 B | 1.58 B | 8.54 B | 1.86 B | 1.86 B | 8.54 B | 1.68 B | 1.89 B | 1.89 B | 1.68 B | 1.92 B | 1.67 B | 1.67 B | 1.92 B | 2.2 B | 1.18 B | 1.18 B | 2.2 B | 750 M | 831 M | 1.18 B | 1.33 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.2 B | 536 M | 2.4 B |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
111 M | $ 67.69 | -1.36 % | $ 13.5 B | ||
|
Glaukos Corporation
GKOS
|
90.8 M | $ 122.49 | -3.05 % | $ 7.01 B | ||
|
Intuitive Surgical
ISRG
|
3.37 B | $ 412.02 | -3.42 % | $ 147 B | ||
|
Alcon
ALC
|
1.53 B | $ 66.11 | -2.64 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
308 M | $ 139.83 | -1.53 % | $ 3.45 B | ||
|
Repro Med Systems
KRMD
|
8.87 M | $ 3.98 | -0.5 % | $ 184 M | ||
|
iRhythm Technologies
IRTC
|
236 M | $ 113.94 | 0.1 % | $ 3.65 B | ||
|
LeMaitre Vascular
LMAT
|
28.2 M | $ 92.34 | -4.4 % | $ 2.09 B | ||
|
Masimo Corporation
MASI
|
178 M | $ 179.95 | - | $ 9.59 B | ||
|
Microbot Medical
MBOT
|
3.91 M | $ 1.77 | -2.75 % | $ 81 M | ||
|
Ekso Bionics Holdings
EKSO
|
1.17 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
1.11 M | $ 0.39 | 0.7 % | $ 32 M | ||
|
Merit Medical Systems
MMSI
|
446 M | $ 66.99 | -0.77 % | $ 3.96 B | ||
|
electroCore
ECOR
|
7.04 M | $ 9.93 | 4.31 % | $ 84.2 K | ||
|
Envista Holdings Corporation
NVST
|
1.21 B | $ 24.06 | -2.16 % | $ 4.04 B | ||
|
Haemonetics Corporation
HAE
|
245 M | $ 78.8 | 0.11 % | $ 3.72 B | ||
|
STERIS plc
STE
|
440 M | $ 208.1 | -2.25 % | $ 20.4 B | ||
|
Isoray
ISR
|
30.6 M | - | 0.03 % | $ 108 M | ||
|
STAAR Surgical Company
STAA
|
153 M | $ 29.33 | -1.81 % | $ 1.45 B | ||
|
InfuSystem Holdings
INFU
|
3.19 M | $ 8.88 | -1.66 % | $ 183 M | ||
|
Teleflex Incorporated
TFX
|
379 M | $ 132.15 | -2.65 % | $ 5.9 B | ||
|
Utah Medical Products
UTMD
|
85.8 M | $ 68.6 | 0.78 % | $ 222 M | ||
|
West Pharmaceutical Services
WST
|
791 M | $ 330.92 | -1.12 % | $ 23.9 B | ||
|
Pulse Biosciences
PLSE
|
80.7 M | $ 24.99 | -3.03 % | $ 1.68 B | ||
|
DENTSPLY SIRONA
XRAY
|
326 M | $ 10.04 | -4.11 % | $ 2 B | ||
|
Retractable Technologies
RVP
|
2.59 M | $ 0.69 | 0.31 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
419 K | $ 61.98 | -4.65 % | $ 204 M | ||
|
Predictive Oncology
POAI
|
10.8 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
33 M | $ 26.66 | -3.23 % | $ 1.27 B | ||
|
Stereotaxis
STXS
|
13.4 M | $ 1.81 | -2.16 % | $ 165 M | ||
|
Baxter International
BAX
|
1.97 B | $ 20.31 | 1.4 % | $ 10.4 B | ||
|
ResMed
RMD
|
274 M | $ 193.57 | -1.71 % | $ 28.3 B | ||
|
AtriCure
ATRC
|
167 M | $ 27.51 | 0.77 % | $ 1.31 B | ||
|
Harvard Bioscience
HBIO
|
8.61 M | $ 6.2 | 2.65 % | $ 275 M | ||
|
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
55.9 M | $ 12.28 | -0.49 % | $ 502 M | ||
|
Nephros
NEPH
|
5.4 M | $ 3.2 | -1.54 % | $ 34 M | ||
|
OraSure Technologies
OSUR
|
199 M | $ 4.03 | -4.95 % | $ 296 M | ||
|
Repligen Corporation
RGEN
|
566 M | $ 130.76 | 0.48 % | $ 7.35 M |